首页|Development and evaluation of a novel biodegradable implants with excellent inflammatory response suppression effect by hot-melt extrusion
Development and evaluation of a novel biodegradable implants with excellent inflammatory response suppression effect by hot-melt extrusion
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
Purpose: Dexamethasone (Dex) is a widely used drug for the treatment of inflammatory and autoimmune conditions, however, long-term systemic use of Dex is associated with serious adverse effects. The objective of the present study was to develop an implantable device to avoid side effects and realize a controlled release of Dex at the implant site. Methods: Hydrophobic Dex was incorporated into biodegradable polyesters derived from PCL and Pluronic (R) L64 (PCL-Pluronic L64-PCL, PCLC) by hot-melt extrusion (HME) method to prepare Dex/PCLC implantable devices. Drug loading and encapsulation efficiency, a series of physicochemical properties, and in vivo features of the implants were studied. Results: The maximum value of the drug loading and encapsulation efficiency for the Dex/PCLC implants were up to 47% and 94%, respectively. Incorporation of Dex resulted in accelerated crystallization of PCLC, decreased the wettability, increased contact angles and viscosity, and accelerated Dex release rate and degradation rate from the implants in vivo. Moreover, Dex/PCLC implants showed excellent biocompatibility. Furthermore, the inflammatory response to the Dex/PCLC implants was less severe than that to the positive control group. Conclusion: All these results suggested that Dex/PCLC implants might be a safe and controlled local drug delivery system with excellent inflammatory response suppression effect.
DexamethasoneInflammationHot-melt extrusionBiocompatibilityImplantable drug delivery system
Fan, Rangrang、Chuan, Di、Hou, Huan、Chen, Haifeng、Xu, Jianguo、Guo, Gang
展开 >
Sichuan Univ, West China Hosp, State Key Lab Biotherapy, 17 Renminnan Rd, Chengdu 610041, Peoples R
Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Peoples R China
NSTL
Elsevier
